Delivery Order SPE2DB24D2215-SPE2DB24FGSHA

Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order against an unidentified contract vehicle to Amerisourcebergen Drug Corp on October 11, 2023. The two hundred twenty-four dollar order is for MEDROXYPROGESTERONE 150 MG/MLML to be delivered to a location in Conshohocken, Pennsylvania by October 12, 2023. No set-aside designation was applied to this order. Performance will be by Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to...

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,207.47 firm fixed-price contract is for the provision of 4564590838 - MEDROXYPROGESTERONE 150 MG/MLML, a pharmaceutical product. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025. The IDC...

This federal contract award, with ID SPE2DB20D3505|SPE2DB22FT4V0, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,221.50 firm fixed-price delivery order is for the supply of Medroxyprogesterone 150 mg/mL, a pharmaceutical product. This contract award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with the DLA Troop Support Medical,...

This is a $1,562.48 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,212,074 milliliters of medroxyprogesterone 150 mg/ml, a medication, with an ultimate completion date of May 13, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...

This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of 4,564,248,049 milliliters of the pharmaceutical drug Medroxyprogesterone Acetate 150 mg/mL. The award has a ceiling value of $5,139.63 and a period of performance through April 12, 2024. This delivery order is issued under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp,...

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,419.96 contract is for the supply of Medroxyprogesterone 150 mg/mL, a medication used in various medical treatments. The contract has a period of performance through September 26, 2023 and is a firm fixed-price contract. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999...

This federal contract award, valued at $2,033.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MEDROXYPROGESTERONE 150 MG/MLML, a medical product, and has an ultimate completion date of May 29, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop...

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,084.90 firm fixed-price delivery order is for the procurement of MEDROXYPROGESTERONE 150 MG/MLML, a specialty medication, with a period of performance through November 8, 2024. The award is not associated with a set-aside program and appears to be part of a larger Indefinite Delivery Contract (IDC) valued at...

The Defense Logistics Agency Troop Support Medical awarded Pfizer Inc., doing business as Pfizer, a $117,080 delivery order for medroxyprogesterone acetate 150mg/ml injectable drug products. This firm fixed price order, placed under an existing contract vehicle, calls for Pfizer to deliver the specified pharmaceutical to an address in New York City by July 13, 2023, in support of the agency's medical supply chain requirements. No set aside provisions or subcontracting arrangements were...

Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide MEDROXYPROGESTERONE 150 MG/ML. The $2,802.66 contract has a completion date of February 27, 2024. This delivery order is issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC allows...